Young Hwan Jung
About Young Hwan Jung
Young Hwan Jung is a Postdoctoral Researcher at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in the United States, focusing on developing small molecule drugs that target G protein-coupled receptors (GPCRs). He holds a PhD from the Gwangju Institute of Science and Technology and has been engaged in drug discovery research since 2018.
Work at National Institutes of Health
Young Hwan Jung has been a Postdoctoral Researcher at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) since 2018. His research focuses on developing small molecule drugs that target G protein-coupled receptors (GPCRs). This work is part of a broader initiative in drug discovery research at the National Institutes of Health, where he has contributed to advancing therapeutic options in the field.
Education and Expertise
Young Hwan Jung completed his Doctor of Philosophy (PhD) at Gwangju Institute of Science and Technology from 2013 to 2017. Prior to that, he earned a Master's degree at the same institution from 2011 to 2013. His academic journey began with a Bachelor's degree in Biochemical Engineering from Dongguk University, which he completed from 2004 to 2011. His educational background provides a strong foundation for his research in drug discovery and GPCR targeting.
Background
Before joining the National Institutes of Health, Young Hwan Jung worked as a Postdoctoral Researcher at Gwangju Institute of Science and Technology from 2017 to 2018. This role lasted four months and contributed to his expertise in biochemical research. His transition to the NIH marked a significant step in his career, allowing him to engage in high-impact research in the United States.
Research Focus
Young Hwan Jung specializes in the development of small molecule drugs that target G protein-coupled receptors (GPCRs). This area of research is critical in pharmacology, as GPCRs are involved in many physiological processes and represent important targets for therapeutic intervention. His work at the NIDDK contributes to the understanding and potential treatment of various diseases related to diabetes, digestion, and kidney function.